The model-driven analyses of CFSE data on proliferative performance of virus-specific CTLs in conjunction with several hypotheses about the control processes of different HIV infection phenotypes allowed us to assess the spectrum of reactions to PD-L1 interventions and to propose biomarker for therapy success. The gene discussed is CD274; the disease is HIV infectious disease.